Grinsztejn, Beatriz
6 papers on CoChatORCID 0000-0003-3692-5155
Most cited papers
- Verified
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine
HIV/AIDS Research and InterventionsHIV Research and Treatment
Cited by 6,873
- Verified
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 2,397
- Verified
Antiretroviral therapy for the prevention of HIV-1 transmission.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine
HIV/AIDS Research and InterventionsHIV Research and Treatment
Cited by 1,700
- Verified
A multinational Delphi consensus to end the COVID-19 public health threat
Lazarus, J. V., Romero, D., Kopka, C. J., Karim, S. A., Abu-Raddad, L. J., Almeida, G., Baptista-Leite, R., Barocas, J. A., Barreto, M. L., Bar-Yam, Y., et al. (2022) · Nature
COVID-19 epidemiological studiesLegal, Health, Environmental and COVID-19 Challenges
Cited by 226
- Verified
Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
Kozal, M., Aberg, J., Pialoux, G., Cahn, P., Thompson, M., Molina, J.-M., Grinsztejn, B., Diaz, R., Castagna, A., Kumar, P., et al. (2020) · New England Journal of Medicine
HIV/AIDS drug development and treatmentHIV Research and Treatment
Cited by 181
- Verified
Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial
Matthews, G., Jacoby, S., Borok, M., Eriobu, N., Kaplan, R., Kumarasamy, N., Bennet, J. A., Avihingsanon, A., Chetchotisakd, P., Wagner Cardoso, S., et al. (2024) · The Lancet HIV
HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free